Population Subjects with type 2 diabetes (n ) Polymorphism (rs) Risk genotype/allele OR (P value)1 Reference Japanese population 536 (PDR versus NDR dm without DR) VEGF2 −634C/G CC—no association 1.5 (0.08) [46 ] Slovak population (Caucasians) 245 (PDR versus dm without PDR) TGF-beta3 +915G/C (R25P) RR genotype 2.89 (<0.01) [42 ] English population (Caucasians) 267 (PDR versus non-PDR) VEGF2 −460C/T, VEGF2 +405C/G CC; no association 3.7 (0.02) NA4 [43 ] Indian population 208 (PDR versus non-PDR) IGF5 -(CA
18-(AC) repeats 2.8 (<0.05) [51 ] Slovak population (Caucasians) 488 (PDR versus non-PDR versus dm without DR) bFGF6 −754C/G CC NA4 (0.006) [44 ] Slovene population (Caucasians) 349 (PDR versus dm without DR) VEGF2 −634C/G CC—no association 1.1 (0.7) [16 ] Polish population (Caucasians) 215 (PDR versus non-PDR versus dm without DR) VEGF2 −634C/G, VEGF2 +460C/T No association NA4 [52 ] Slovene population (Caucasians) 313 (PDR versus dm without DR) bFGF6 : −553T/A, −834T/A, −921C/G −553T/A AT genotype; −834T/A AT genotype 2.0 (0.03); 0.4 (0.01); no association; consecutively [17 ] South Korean population 398 (PDR versus non-PDR versus dm without DR) VEGF2 −936C/T TT NA4 [45 ] Australian population 364 (PDR versus non-PDR versus dm without DR) VEGF2 —rs3025021 and rs10434, consecutively C allele rs3025021 G allele 3.8 (0.002) 2.6 (0.002) [46 ] Japanese population 364 (PDR versus dm without DR) VEGF2 −634C/G; −2578C/A No association; AA genotype No association; 7.7 (0.002) [47 ] Han Chinese population 285 (PDR versus non-PDR versus dm without DR) VEGF2 −634C/G No association NA4 (0.6) [48 ] South Korean population 387 (PDR versus non-PDR versus dm without DR) rs699947, rs1570360, and rs2010963—VEGF2 AGG haplotype 4.3 (
) [49 ] Iranian population 398 (PDR versus NDR) VEGF2 +405 GG 1.87 (
) [50 ]